Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/19/2010US20100209400 TAK1-Mediated Regulation of Osteogenesis
08/19/2010US20100209393 Use of Polynucleotides Encoding Small Acid-Soluble Spore Protein for Inhibiting Bacterial Cell Growth and/or Treating Bacterial Infections
08/19/2010US20100209391 Novel inhibitors of hepatitis c virus replication
08/19/2010US20100209389 Multi-Compartmented Container
08/19/2010US20100209386 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
08/19/2010US20100209384 Sustained release formulations comprising very low molecular weight polymers
08/19/2010US20100209382 Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use
08/19/2010US20100209380 Adhesive formulations
08/19/2010US20100209368 Method and preparation for treating baldness
08/19/2010US20100209364 Emulsified Composition
08/19/2010US20100209358 Method of Making Particles For Use In A Pharmaceutical Composition
08/19/2010US20100209357 Localized Therapy of Lower Airways Inflammatory Disorders with Proinflammatory Cytokine Inhibitors
08/19/2010US20100209354 Organic/inorganic hybrid nanoparticulates made from iron carboxylates
08/19/2010US20100209351 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
08/19/2010US20100209350 Biomarkers for Adipose Tissue Activity
08/19/2010US20100209345 Fluorinated Ligands for Targeting Peripheral Benzodiazepine Receptors
08/19/2010US20100209342 Apcdd1 inhibitors for treating, diagnosing or detecting cancer
08/19/2010US20100209340 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
08/19/2010DE202010006870U1 Salbe zur Behandlung der Mortellaro-Krankheit Ointment for the treatment of hairy wart disease
08/19/2010DE102009009245A1 Composition useful for prevention and treatment of viral infections, preferably influenza, conjunctivitis or cervicitis and secondary infections that are associated with it, comprises an agglutination inhibitor
08/19/2010DE102009008851A1 Transdermal system, useful for treating multiple sclerosis and Crohn's disease, comprises an immunomodulator comprising e.g. quinoline, active agent impermeable protective layer, active agent reservoir and a carrier
08/19/2010DE102009008186A1 Feste orale pharmazeutische Zusammensetzung umfassend einen hydrophoben Wirkstoff A solid oral pharmaceutical composition comprising a hydrophobic drug
08/19/2010DE102009008185A1 Zusammensetzung umfassend einen hydrophoben Wirkstoff sowie ein Phospholipid A composition comprising a hydrophobic drug and a phospholipid
08/19/2010DE102009007771A1 Bukkales Applikationssystem, 17α-Estradiol enthaltend Buccal delivery system, 17α-estradiol containing
08/19/2010CA2789641A1 Diazepinedione derivative
08/19/2010CA2789512A1 Compounds and methods for inhibiting mmp2 and mmp9
08/19/2010CA2789365A1 Methods for treating non-small cell lung cancer using 5-azacytidine
08/19/2010CA2781830A1 Materials and methods for treating developmental disorders inclucing comorbid and idiopathic autism
08/19/2010CA2755935A1 Hetero ring derivative
08/19/2010CA2754134A1 Stable pharmaceutical composition for atherosclerosis
08/19/2010CA2752626A1 Methods of treating hair related conditions
08/19/2010CA2752623A1 Alkylamido compounds and uses thereof
08/19/2010CA2752557A1 Anti-fungal formulation
08/19/2010CA2752544A1 Solid forms of 2-(2, 4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide
08/19/2010CA2752437A1 Antidiabetic medications
08/19/2010CA2752435A1 Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
08/19/2010CA2752434A1 Pharmaceutical composition comprising linagliptin and a sglt2 inhibitor
08/19/2010CA2752389A1 Skin treatment
08/19/2010CA2752269A1 Novel triazine derivative and pharmaceutical composition comprising the same
08/19/2010CA2752249A1 Products comprising n-phenylpropenoyl amino acid amides and uses thereof
08/19/2010CA2752233A1 Controlled release pharmaceutical formulations of nitazoxanide
08/19/2010CA2752232A1 Combinational compositions and methods for treatment of cancer
08/19/2010CA2752206A1 Valproic acid drug delivery systems and intraocular therapeutic uses thereof
08/19/2010CA2752199A1 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof
08/19/2010CA2752198A1 Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
08/19/2010CA2752156A1 4-(1-(3-(hydroxymethyl)-2-methylphenyl)ethyl)-1h-imidazole-2(3h)-thione
08/19/2010CA2752150A1 Selective kinase inhibitors
08/19/2010CA2752148A1 Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
08/19/2010CA2752129A1 Sodium nitrite-containing pharmaceutical compositions
08/19/2010CA2752114A1 Fused pyrimidines as akt inhibitors
08/19/2010CA2752074A1 Toll-like receptor modulators and treatment of diseases
08/19/2010CA2752073A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/19/2010CA2752070A1 Foamable benzoyl peroxide compositions for topical administration
08/19/2010CA2752020A1 Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
08/19/2010CA2751977A1 C-cbl and antagonists thereof for the treatment and diagnosis of cancer
08/19/2010CA2751886A1 Novel amino azaheterocyclic carboxamides
08/19/2010CA2751866A1 N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
08/19/2010CA2751863A1 N-[(2-azabicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
08/19/2010CA2751834A1 Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof
08/19/2010CA2751833A1 Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabete mellitus, impaired glucose tolerance or hyperglycemia
08/19/2010CA2751625A1 Device and method for producing pharmaceutically highly refined particles and for coating said particles in microreactors
08/19/2010CA2751581A1 Compositions and methods for extended therapy with aminopyridines
08/19/2010CA2751576A1 Methods of treating hypertriglyceridemia
08/19/2010CA2751543A1 Combination of avermectins or mylbemycins with adrenergic receptors for treating or preventing skin diseases
08/19/2010CA2751517A1 [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
08/19/2010CA2751501A1 2-morpholino-pyrido[3,2-d]pyrimidines
08/19/2010CA2751478A1 Derivatives of azaindoles as inhibitors of protein kinases abl and src
08/19/2010CA2751449A1 Foamable microemulsion compositions for topical administration
08/19/2010CA2751393A1 Pharmaceutical compositions of 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate
08/19/2010CA2751385A1 Novel salts of sitagliptin
08/19/2010CA2751277A1 Carba-nucleoside analogs for antiviral treatment
08/19/2010CA2751271A1 A composition for buccal absorption of nicotine for the purpose of smoking cessation
08/19/2010CA2751260A1 Phenoxy acetic acid derivatives
08/19/2010CA2751243A1 Spiroindolinone pyridine derivative
08/19/2010CA2750913A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/19/2010CA2750793A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/19/2010CA2750242A1 Drug delivery through hydrogel plugs
08/19/2010CA2750125A1 Methods for preparing s1p receptor agonists and antagonists
08/19/2010CA2750123A1 Methods of using and compositions comprising pde4 modulators for treatment, prevention and management of tuberculosis
08/19/2010CA2749994A1 Crystalline polymorphic form 631
08/19/2010CA2749960A1 Agonists and antagonists of the s1p5 receptor, and methods of uses thereof
08/19/2010CA2749926A1 Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer
08/19/2010CA2749350A1 Prediction of response to platinum-based therapy
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218734A2 Glucagon-like peptide-2 analogs
08/18/2010EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218730A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218722A2 Process for producing benzoxazine derivative and production intermediate thereof
08/18/2010EP2218721A1 Novel salts of sitagliptin
08/18/2010EP2218720A1 2-2'-Bis-thiazole derivatives as antiviral agents
08/18/2010EP2218719A1 Abcg2 inhibitor
08/18/2010EP2218718A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
08/18/2010EP2218716A1 Method for amplifying hematopoietic stem cells using heterocyclic compound
08/18/2010EP2218713A1 Erlotinib hydrochloride polymorph Form A substantially free of polymorph Form B
08/18/2010EP2218712A1 Combination of anti-angiogenic substance and anti-tumor platinum complex
08/18/2010EP2218480A2 Use of creatine and/or creatine derivatives in cosmetic or dermatological preparations
08/18/2010EP2218462A1 Pharmaceutical preparation for the treatment of depressive pathologies, comprising a protein with a high tryptophan/LNAAs (Large Neutral Amino Acids) ratio
08/18/2010EP2218460A2 Quality control methods for oil-in-water emulsions containing squalene
08/18/2010EP2218454A1 Pharmaceutical composition combining acemetacin, methocarbamol and diacerein, which can be used in the treatment of rheumatoid arthritis and related diseases
1 ... 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 ... 7860